Tag | Content |
---|
EnhancerAtlas ID | HS182-11516 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr19:47121700-47122640 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Myod1 | MA0499.1 | chr19:47122201-47122214 | AGCAACAGCTGCA | - | 6.64 | Myog | MA0500.1 | chr19:47122204-47122215 | AACAGCTGCAG | + | 6.02 | Nr5a2 | MA0505.1 | chr19:47122044-47122059 | GGTGACCTTGACCTG | - | 6.35 | SP8 | MA0747.1 | chr19:47122384-47122396 | CCCACGCCCACT | + | 6.14 | Tcf12 | MA0521.1 | chr19:47122204-47122215 | AACAGCTGCAG | + | 6.62 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_16239 | chr19:47121829-47123428 | CD4_Naive_Primary_7pool |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr19 | 47121981 | 47122214 | chr19 | 47121796 | 47122499 |
|
Enhancer Sequence | CAGGCCAGCA CCCAGCTAAT TTTTTTATTA TTATTTGTAG AAACAGGTTC TTGATATGTT 60 GCCCAGGCTG GTCTTGAACT CCTGGGCTCA GGGGATCCTC CCGCCTCAGC CTCCCAAAAT 120 GCAGGGATTA CAGATGGGAA TCACCTCGCC CTGCCTACTT ACTTTATTTT TTAAATTTTT 180 TTTTAATCGC AGTAAGATAC ACATAACATA AAAGTTGCTA TTTTAACCAT TCAAAGTTAC 240 AATTCAGTGG CATTCAGTGC ATTCACACTG TTGAGCAACC CTCACTACTA TCCAATTCCA 300 GAACATTTTC ATCACCCCAA AGGGGAACCC CAAGCTCATT CATGGGTGAC CTTGACCTGT 360 TTTTAACTCT CCCAGACACC CCTTGTTCTG CTTTATTGTG ATTTGAAACG TGGTTACCTG 420 GGCAGGGTGG GGGAAGTCAA AACACCCGAA CCAGAGCCAG GAGGTGGTTT CCTTTTAAAT 480 TGTATCTGTC CAAATAACAA TAGCAACAGC TGCAGCAATG GCAATCATAG TGACATTTCT 540 TATGGGCTTT ATTCCAAGCC CTGAGCTAAT TTGCTTTTCA GAGGGAATTG CTTAATCCCC 600 AAAGCCGCCA TGCAAGCTAA GTGCTAGATT ATGATCAAAA GGAAACCAAG GTGTCCCGGA 660 GTGGATAGAC GGGCCTGCTC CAAGCCCACG CCCACTCGCT GTGTGAGTCG GGACAGGTGG 720 ATTATCATCT CTGGACCTGG ACTCCGTCTT CTGTAGAAAG GACTTATTGC TGGGCTCAGA 780 GGCTCCCACC TGTAATCCAA GCATTTTGGG AGGCTGAGGT GGGAGGATCA CTTGAGGTCA 840 GGAGTTCGAG ACCAGCCTGG CCAACGTGAC GAAACCCCGT CTCTACTACA AATACAAAAA 900 AATTAGCCAG AGGTGGTGGT GCACGCCTGT AATCCCAGCT 940
|